Loading...
DOCUMENTS
21
NOTICES
32
MOTS CLES
Gene methylation
IBD
Eligibility
MALT
Stricture
Upper gastrointestinal tract
18 FDG-PET/CT
Drug
Resistance
Disease Progression
Rituximab plus chlorambucil
Crohn's disease
Methylation
Venous thromboembolism
RISK
MORTALITY
Screening
Tailored therapy
T1118 translocation
Over 80s
CARCINOGENESIS
Epigenetics
Inclusion
Endoscopic treatment
Crohn’s disease
Rituximab
Immune cells
Therapeutics
Consensus
Neoadjuvant chemotherapy
Original Article Clinical
Gènes
MICROBIOTA
Acceptability
Parvimonas micra
Inflammatory bowel diseases
Immunosuppressant
Intestinal crypts
Vedolizumab
Disease progression
Alkylating agents
DNA methylation
Ulcerative colitis
Résistance
IL23
Colon
Méthylation
HIV
Cell adhesion
Bacteria
Colon cancer
PCR
Anti-TNF
Microbiota
Effectiveness
Clinical guidelines
Inflammatory bowel disease
Microbiote
Thérapie ciblée
Dysbiosis
Eradication
Cancer
Survival
Clinical trial
Inflammatory Bowel Diseases
Dysbiose
Inhibitor
Helicobacter pylori
Safety
Disability
Colorectal cancer
Bactéries
Kidney diseases
Anti-TNF agents
Algorithm
Contraindication
Primary sclerosing cholangitis
Tuberculosis
Biomarker
Genes
Epigénétiques
Ustekinumab
Cost effectiveness
Colonic epithelial primary cells
Gene expression
COLON-CANCER
Patient-reported outcome
Biologics
Colorectal cancer Colibactin and lipids
Maintenance therapy
Patients experience
Monitoring
Fecal microbiota
Small molecules
Colectomy
IL12
MARKER
Heart disease risk factors
Surgery
DNA METHYLATION
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|
Derniers dépôts
-
Lucas Guillo, Mathieu Uzzan, Laurent Beaugerie, Jean-Marc Gornet, Aurélien Amiot, et al.. Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study. Clinical Gastroenterology and Hepatology, 2022, 20 (4), pp.787-797.e2. ⟨10.1016/j.cgh.2020.12.023⟩. ⟨hal-04168380⟩
-
Iradj Sobhani, Emma Bergsten, Cecile Charpy, Mathias Chamaillard, Denis Mestivier. Virulent Bacteria as Inflammatory and Immune Co-Factor in Colon Carcinogenesis: Evidence From Two Monozygotic Patients and Validation in CRC Patient and Healthy Cohorts. Frontiers in Cellular and Infection Microbiology, 2021, 11, pp.749750. ⟨10.3389/fcimb.2021.749750⟩. ⟨hal-04543208⟩
-
Lucas Guillo, Guillaume Savoye, Aurélien Amiot, Cyrielle Gilletta, Maria Nachury, et al.. Prevalence of and factors associated with extraintestinal manifestations and their remission in inflammatory bowel disease: the EXTRA prospective study from the GETAID. Clinical and translational gastroenterology, 2023, 14 (12), pp.e00607. ⟨10.14309/ctg.0000000000000607⟩. ⟨hal-04206330⟩
-
Florence Canouï-Poitrine, Astrid Lièvre, Florent Dayde, Daniel Lopez-Trabada-Ataz, Isabelle Baumgaertner, et al.. Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey. Oncologist, 2019, 24 (12), pp.e1351-e1359. ⟨10.1634/theoncologist.2019-0166⟩. ⟨hal-04126614⟩
-
Maria Nachury, Yoram Bouhnik, Mélanie Serrero, Jerome Filippi, Xavier Roblin, et al.. Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group. Digestive and Liver Disease, 2021, 53 (4), pp.434-441. ⟨10.1016/j.dld.2020.10.020⟩. ⟨hal-03038260⟩
-
Julien Tap, Aurélien Amiot, Véronique Jarrousse, Sandra Guilmeau, Jeanne Tran Vannhieu, et al.. Early Phenotypical Changes Induced By Transfer Of Human Fecal Microbiota from Colorectal Cancer Patients To Germ-Free Mice. International Journal of Cancer and Oncology, 2017, 4 (1), pp. 1-11. ⟨10.15436/2377-0902.16.1128⟩. ⟨hal-03825702⟩
-
Nicolas Petitdidier, Laurent Beaugerie, Franck Carbonnel, Anne Bourrier, Xavier Treton, et al.. Real-world use of therapeutic drug monitoring of CT-P13 in patients with inflammatory bowel disease: A 12-month prospective observational cohort study. Clinics and Research in Hepatology and Gastroenterology, 2020, 44, pp.609 - 618. ⟨10.1016/j.clinre.2019.11.008⟩. ⟨hal-03492351⟩